MAKING GREAT DRUGS BETTER

News

ExSight Ventures discuss why they invested into Re-Vana

by | Jan 13, 2021 | News | 0 comments

In the OIS Podcast, ExSight Ventures discuss why they invested into Re-Vana. Here is the segment where they discuss Re-Vana Therapeutics: 

Listen to the Full Podcast Here

(Discussion of Re-Vana commences at 43 minutes.)

https://ois.net/venturing-into-ophthalmology-with-exsight-podcast/

OIS PODCAST 263 Michael Nissen, James Murray, Venturing into Ophthalmology with ExSight
Re-Vana: Vision In The Future